SCHEMBL23153302

SCHEMBL23153302

CC(C)(C)c1cc2cc(CC(C)(C)c3cc4cc(F)ccc4[nH]3)ccc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.39
FFAR1 O14842 1/20 0.39
PPARG P37231 1/20 0.39
CNR1 P21554 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PDPK1 O15530 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
APEX1 P27695 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DAO P14920 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22024963 0.93 CYP1A1 (0.36) CYP1A1FFAR1PPARGCNR1NR3C1
SCHEMBL12574858 0.85 KDM4E (0.47) CYP1A1KDM4EPDPK1ALDH1A1LMNA
SCHEMBL24351927 0.80 NR3C1 (0.34) CYP1A1FFAR1PPARGCNR1NR3C1
SCHEMBL22330391 0.76 NR3C1 (0.39) CYP1A1NR3C1PGRNR3C2CNR2
SCHEMBL10211331 0.76 KDM4E (0.43) KDM4EALDH1A1LMNATDP1DAO
SCHEMBL21214072 0.74 GAA (0.42) KDM4EALDH1A1LMNAHPGDTDP1
SCHEMBL16382897 0.74 SYK (0.53) KDM4EALDH1A1LMNAHPGDTDP1
SCHEMBL26315676 0.73 NPSR1 (0.41) KDM4EALDH1A1LMNAHPGDCYP2C19
SCHEMBL21015898 0.72 AHR (0.36) ALDH1A1LMNAHPGDDAOMAPT
SCHEMBL4568030 0.72 DAO (0.47) NR3C1PGRNR3C2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961252-B2 Quinazoline and indole compounds to treat medical disorders ACHILLION PHARMACEUTICALS, INC. (US) 2021-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961252-B2 Quinazoline and indole compounds to treat medical disorders CFB, TFPI, MAOB CYP1A1 440/4885FFAR1 4469/4885PPARG 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.